Cleared Traditional

PHACO-INJECTOR(TM) INTRAOCULAR LENS IMPLANT INSTR (K893199) - FDA 510(k) Clearance

Class I Ophthalmic device.

K893199 · Allergan Medical Optics · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1989
Decision
51d
Days
Class 1
Risk

K893199 is an FDA 510(k) clearance for the PHACO-INJECTOR(TM) INTRAOCULAR LENS IMPLANT INSTR. Classified as Forceps, Ophthalmic (product code HNR), Class I - General Controls.

Submitted by Allergan Medical Optics (Anasco, US). The FDA issued a Cleared decision on June 16, 1989 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4350 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Allergan Medical Optics devices

Submission Details

510(k) Number K893199 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 1989
Decision Date June 16, 1989
Days to Decision 51 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 110d · This submission: 51d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HNR Forceps, Ophthalmic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 886.4350
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.